MedTrace Logo

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

NCT02722395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2017-04-06

No results posted yet for this study

Summary

This study is a research and development initiative established to explore the use of magnetic resonance imaging (MRI) as a tool for managing organ motion of the liver in cancer patients planning procedures for stereotactic body radiation therapy (SBRT).

Conditions

  • Primary Liver Cancer
  • Metastatic Liver Cancer From Any Cancer Site

Sponsors & Collaborators

Principal Investigators

  • Brian Czito · Duke University

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-02-01
Completion
2017-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02722395 on ClinicalTrials.gov